source
- More drugmakers look to standalone medical devices for combo productsBALTIMORE – Drugmakers that want to develop standalone medical devices to be used in combination with their drugs should evaluate the devices’ capabilities and requirements while engaging health au…raps · 1d ago↗ source
- FDA finalizes guidance on transferring 510(k) ownershipThe US Food and Drug Administration (FDA) has finalized a guidance that outlines the responsibilities of owners of 510(k) clearances when products are sold or transferred between companies. The fin…raps · 1d ago↗ source
- FDA approves Infilbray, first therapy for neurological symptoms of Type 3 Gaucher diseaseThe U.S. Food and Drug Administration has approved Infilbray (venglustat) tablets for treating the neurological manifestations of Type 3 Gaucher disease in adults and children weighing at least 15…